AstraZeneca: Clinical Trials & FDA Approval Profile
AstraZeneca (Cambridge, UK / Wilmington, DE) sponsors 534 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 300 active protocols (134 recruiting now), 175 completed protocols, and 81 all-time original FDA Drugs@FDA NDA and BLA approvals.